Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Completed
- Conditions
- Burkitt LymphomaHodgkin LymphomaLymphomaAnaplastic Large Cell LymphomaDiffuse Large B-Cell Lymphoma
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Questionnaire Administration
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 203
- Registration Number
- NCT01793233
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈArkansas Children's Hospital, Little Rock, Arkansas, United States
πΊπΈKaiser Permanente Downey Medical Center, Downey, California, United States
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Recruiting
- Conditions
- OsteosarcomaRecurrent LeukemiaLymphoblastic LymphomaHodgkin Lymphoma in RemissionLeukemia in RemissionRecurrent LymphomaRecurrent Malignant Neoplasm
- Interventions
- Other: Assessment of Therapy ComplicationsOther: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2013-02-13
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 420
- Registration Number
- NCT01790152
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
πΊπΈBanner University Medical Center - Tucson, Tucson, Arizona, United States
Biomarkers in Patients With Advanced Rhabdomyosarcoma
Completed
- Conditions
- Childhood Embryonal RhabdomyosarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaChildhood Alveolar RhabdomyosarcomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood RhabdomyosarcomaStage IV Adult Soft Tissue SarcomaAdult Rhabdomyosarcoma
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2012-08-17
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 10
- Registration Number
- NCT01668095
- Locations
- πΊπΈ
Children's Oncology Group, Philadelphia, Pennsylvania, United States
Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
Completed
- Conditions
- Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 100
- Registration Number
- NCT01642069
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesChildhood Acute Monoblastic Leukemia (M5a)Childhood Acute Myelomonocytic Leukemia (M4)Childhood Acute Monocytic Leukemia (M5b)
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01642121
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
Withdrawn
- Conditions
- Congenital Mesoblastic NephromaChildhood Kidney NeoplasmRhabdoid Tumor of the KidneyClear Cell Renal Cell Carcinoma
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT01642095
- Locations
- πΊπΈ
Childrens Oncology Group, Philadelphia, Pennsylvania, United States
Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial
Completed
- Conditions
- Leukemia
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT01629745
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
Completed
- Conditions
- Embryonal Childhood RhabdomyosarcomaRecurrent Childhood RhabdomyosarcomaAlveolar Childhood RhabdomyosarcomaPreviously Untreated Childhood RhabdomyosarcomaPreviously Treated Childhood Rhabdomyosarcoma
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2012-06-22
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01626170
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2012-06-22
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01626183
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
Completed
- Conditions
- Recurrent Childhood Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaUntreated Childhood Acute Lymphoblastic Leukemia
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 40
- Registration Number
- NCT01625143
- Locations
- πΊπΈ
Children's Oncology Group, Arcadia, California, United States